NO914250L - Fremgangsmaate for fremstilling av piperazinderivater - Google Patents

Fremgangsmaate for fremstilling av piperazinderivater

Info

Publication number: NO914250L
Authority: NO; Norway
Prior art keywords: procedure; piperazine derivatives; preparing piperazine; preparing; derivatives
Prior art date: 1990-10-31

Application number

NO91914250A

Other languages

English (en)

Norwegian (no)

Other versions

NO914250D0 (no

Inventor

Eva Agai

Tibor Gizur

Kalman Harsanyi

Ferenc Trischler

Aniko Demeter

Attila Csehi

Eva Vajda

Gyoergyi Szabo

Original Assignee

Richter Gedeon Vegyeszet

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-10-31

Filing date

1991-10-30

Publication date

1992-05-04

1991-10-30 Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet

1991-10-30 Publication of NO914250D0 publication Critical patent/NO914250D0/no

1992-05-04 Publication of NO914250L publication Critical patent/NO914250L/no

Links

GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical class C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 title 1
229940066771 systemic antihistamines piperazine derivative Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Cardiology (AREA)
Veterinary Medicine (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO91914250A 1990-10-31 1991-10-30 Fremgangsmaate for fremstilling av piperazinderivater NO914250L (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
HU906953A HU209723B (en)	1990-10-31	1990-10-31	Process for producing of piperazine derivatives

Publications (2)

Publication Number	Publication Date
NO914250D0 NO914250D0 (no)	1991-10-30
NO914250L true NO914250L (no)	1992-05-04

Family

ID=10972063

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO91914250A NO914250L (no)	1990-10-31	1991-10-30	Fremgangsmaate for fremstilling av piperazinderivater

Country Status (11)

Country	Link
EP (1)	EP0483932A1 (cs)
JP (1)	JPH04264078A (cs)
KR (1)	KR920008018A (cs)
AU (1)	AU8683091A (cs)
CA (1)	CA2054544A1 (cs)
CS (1)	CS329491A3 (cs)
HU (1)	HU209723B (cs)
NO (1)	NO914250L (cs)
PL (1)	PL292227A1 (cs)
PT (1)	PT99368A (cs)
ZA (1)	ZA918636B (cs)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0585500A1 (en) *	1992-09-04	1994-03-09	Merrell Dow Pharmaceuticals Inc.	Diaryl piperazineacetamides as antimuscarinic agents
CA2657986A1 (en) *	2000-02-22	2001-08-30	Cv Therapeutics, Inc.	Substituted piperazine compounds
US6552023B2 (en)	2000-02-22	2003-04-22	Cv Therapeutics, Inc.	Aralkyl substituted piperazine compounds
US6451798B2 (en)	2000-02-22	2002-09-17	Cv Therapeutics, Inc.	Substituted alkyl piperazine derivatives
US6638970B2 (en)	2000-02-22	2003-10-28	Cv Therapeutics, Inc.	Substituted alkylene diamine compounds
US6677343B2 (en)	2000-02-22	2004-01-13	Cv Therapeutics, Inc.	Substituted piperazine compounds
US6677336B2 (en)	2000-02-22	2004-01-13	Cv Therapeutics, Inc.	Substituted piperazine compounds
KR100797835B1 (ko) *	2001-08-13	2008-01-24	주식회사 포스코	핀치롤의 이물질 제거장치
JP2006514066A (ja)	2003-01-03	2006-04-27	シーブイ・セラピューティクス・インコーポレイテッド	置換ヘテロ環化合物
KR20060065586A (ko)	2003-06-23	2006-06-14	씨브이 쎄러퓨틱스, 인코포레이티드	지방산 산화 저해제로서의, 피페라진 및 피페리딘의 우레아유도체
WO2005061470A1 (en) *	2003-12-18	2005-07-07	Cv Therapeutics, Inc.	1-akan-2-ol substituted piperazine and piperidine compounds
WO2006008753A1 (en) *	2004-07-19	2006-01-26	Unichem Laboratories Limited	Crystalline and amorphous form of ranolazine and the process for manufacturing them
WO2008047388A2 (en) *	2006-10-20	2008-04-24	Ind-Swift Laboratories Limited	Improved process for the preparation of ranolazine
WO2008139492A2 (en) *	2007-05-15	2008-11-20	Natco Pharma Limited	A process for the preparation of highly pure ranolazine base
US20110300218A1 (en) *	2008-09-09	2011-12-08	Actavis Group Ptc Ehf	Novel solid state forms of ranolazine salts
US20110223213A1 (en) *	2008-10-15	2011-09-15	Actavis Group Ptc Ehf	Highly pure ranolazine or a pharmaceutically acceptable salt thereof
WO2010097805A1 (en)	2009-02-24	2010-09-02	Lupin Limited	A process for the preparation of ranolazine
EP3782992A1 (en)	2015-03-10	2021-02-24	Unichem Laboratories Limited	Novel process for the preparation of ranolazine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB662283A (en) *	1948-08-02	1951-12-05	Rhone Poulenc Sa	Improvements in or relating to piperazine compounds
US4567264A (en) *	1983-05-18	1986-01-28	Syntex (U.S.A.) Inc.	Cardioselective aryloxy- and arylthio- hydroxypropylene-piperazinyl acetanilides which affect calcium entry

1990
- 1990-10-31 HU HU906953A patent/HU209723B/hu not_active IP Right Cessation
1991
- 1991-10-29 PT PT99368A patent/PT99368A/pt not_active Application Discontinuation
- 1991-10-30 JP JP3285053A patent/JPH04264078A/ja active Pending
- 1991-10-30 ZA ZA918636A patent/ZA918636B/xx unknown
- 1991-10-30 CA CA002054544A patent/CA2054544A1/en not_active Abandoned
- 1991-10-30 CS CS913294A patent/CS329491A3/cs unknown
- 1991-10-30 PL PL29222791A patent/PL292227A1/xx unknown
- 1991-10-30 KR KR1019910019180A patent/KR920008018A/ko not_active Withdrawn
- 1991-10-30 NO NO91914250A patent/NO914250L/no unknown
- 1991-10-30 AU AU86830/91A patent/AU8683091A/en not_active Abandoned
- 1991-10-31 EP EP91202836A patent/EP0483932A1/en not_active Withdrawn

Also Published As

Publication number	Publication date
PL292227A1 (en)	1992-06-26
HU906953D0 (en)	1991-05-28
KR920008018A (ko)	1992-05-27
NO914250D0 (no)	1991-10-30
CS329491A3 (en)	1992-05-13
AU8683091A (en)	1992-05-07
CA2054544A1 (en)	1992-05-01
ZA918636B (en)	1992-08-26
HUT62278A (en)	1993-04-28
PT99368A (pt)	1992-09-30
HU209723B (en)	1994-10-28
JPH04264078A (ja)	1992-09-18
EP0483932A1 (en)	1992-05-06

Publication	Publication Date	Title
FI914163A7 (fi)	1992-03-26	Heterosykliset johdannaiset
NO913234L (no)	1992-02-21	Fremgangsmaate for fremstilling av pyrazolderivater.
FI930799L (fi)	1993-02-23	Piperazinylderivat
NO914250D0 (no)	1991-10-30	Fremgangsmaate for fremstilling av piperazinderivater
NO913745D0 (no)	1991-09-24	Fremgangsmaate for fremstilling av 1,3-benzoksazinderivater
NO920965L (no)	1992-09-16	Fremgangsmaate for fremstilling av etylen-alfa-olefinkopolymerer
NO924028L (no)	1992-10-16	Forbedret fremgangsmaate for fremstilling av substituerte indolonderivater
NO901070L (no)	1990-10-01	Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
NO914056D0 (no)	1991-10-16	Fremgangsmaate for fremstilling av 5h-benzodiazepinderivat
FI921319A7 (fi)	1992-03-26	Menetelmä kinoliinijohdannaisten valmistamiseksi
NO901071L (no)	1990-10-01	Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
DK91890A (da)	1990-10-16	Piperazin-derivater
GB2248837B (en)	1994-05-04	Piperazine derivatives
NO914053L (no)	1992-04-21	Fremgangsmaate for fremstilling av 8-klorokinolonderivater
NO912980D0 (no)	1991-07-31	Fremgangsmaate for fremstilling av 2-(9-fluorenoyl)-carbapenderivater
NO925007D0 (no)	1992-12-23	Fremgangsmaate for fremstilling av benzofuranylimidazolderivater
NO893713D0 (no)	1989-09-18	Fremgangsmaate for fremstilling av benzoksazolon-derivater.
NO914985L (no)	1992-06-19	Fremgangsmaate for fremstilling av 15-nitro-tabersonin-derivater
FI911633A7 (fi)	1991-10-28	Menetelmä alkaanisulfoanilidijohdosten valmistamiseksi
NO914452L (no)	1992-05-15	Fremgangsmaate for fremstilling av isokinolinderivater
FI913656A7 (fi)	1992-02-01	Menetelmä alkyyli-6-pyridatsiinijohdannaisten valmistamiseksi
NO901069L (no)	1991-09-09	Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
NO901812L (no)	1991-10-25	Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
NO923481D0 (no)	1992-09-07	Fremgangsmaate for fremstilling av 1-hydroksyalkyl-5-nitroimidazol
FI944968L (fi)	1994-10-21	Menetelmä sakkariinijohdannaisten valmistamiseksi